Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
Illumina Radiopharmaceuticals
AddedFeb 19, 2024
UpdatedJun 18, 2026
Illumina Radiopharmaceuticals

Illumina Radiopharmaceuticals

Illumina Radiopharmaceuticals, a NYC-based organization founded in 2019.

HQ
New York City, NY, US
Founded
2019
Overview
Compare
Fundraising
Employees

Illumina Radiopharmaceuticals, founded in 2019 and based in New York City, focuses on developing advanced radiopharmaceuticals for cancer diagnosis and treatment. The company aims to innovate in the field of nuclear medicine, providing cutting-edge solutions to improve patient outcomes and enhance the accuracy of cancer detection.

Since its inception, Illumina Radiopharmaceuticals has made significant strides in the radiopharmaceutical industry, contributing to advancements in cancer care. The company's efforts have garnered attention from leading healthcare professionals and investors, positioning it as a notable player in the medical technology sector.

Illumina Radiopharmaceuticals - Similar Companies

Radionetics Oncology logo

Radionetics Oncology

radionetics.com

Nucleus RadioPharma logo

Nucleus RadioPharma

nucleusrad.com

Radiomedix logo

Radiomedix

radiomedix.com

Mariana Oncology logo

Mariana Oncology

NuView Life Sciences logo

NuView Life Sciences

Evergreen Theragnostics logo

Evergreen Theragnostics

evergreentgn.com

Sabik Medical logo

Sabik Medical

Lumiphore logo

Lumiphore

lumiphore.com

XRad Therapeutics logo

XRad Therapeutics

RadioRx logo

RadioRx

radiorx.com

Ratio Therapeutics logo

Ratio Therapeutics

ratiotx.com

Coqui Radio Pharmaceuticals logo

Coqui Radio Pharmaceuticals

Radiosight logo

Radiosight

radiosight.com

Aktis Oncology logo

Aktis Oncology

aktisoncology.com

Oncurie logo

Oncurie

oncurie.com

Illumina Radiopharmaceuticals - Quick Facts

Who are Illumina Radiopharmaceuticals' competitors?

Companies similar to Illumina Radiopharmaceuticals include Radionetics Oncology, Nucleus RadioPharma, Radiomedix and Mariana Oncology.

When was Illumina Radiopharmaceuticals founded?

Illumina Radiopharmaceuticals was founded in 2019.

Where is Illumina Radiopharmaceuticals' headquarters located?

Illumina Radiopharmaceuticals' headquarters is located in New York City, NY, US.

How much has Illumina Radiopharmaceuticals raised to-date?

As of Aug 11, 2022, Illumina Radiopharmaceuticals has raised a total of $250k (USD).

How many employees does Illumina Radiopharmaceuticals have?

Illumina Radiopharmaceuticals has 6 employees as of Feb 5, 2024.

Illumina Radiopharmaceuticals - Classification

Ownership
  • Private
Technology
  • Biotech
Geographic Exposure
  • United States
Revenue
  • Recurring
  • Software
Customer
  • Enterprise
Main Product
  • Radiopharmaceuticals
Tags
  • Healthtech